IN152828B - - Google Patents

Info

Publication number
IN152828B
IN152828B IN513/CAL/81A IN513CA1981A IN152828B IN 152828 B IN152828 B IN 152828B IN 513CA1981 A IN513CA1981 A IN 513CA1981A IN 152828 B IN152828 B IN 152828B
Authority
IN
India
Application number
IN513/CAL/81A
Other languages
English (en)
Inventor
Jean Mardiguian
Original Assignee
Pharmindustrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9241965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN152828(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmindustrie filed Critical Pharmindustrie
Publication of IN152828B publication Critical patent/IN152828B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
IN513/CAL/81A 1980-05-14 1981-05-14 IN152828B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8010791A FR2482611B1 (fr) 1980-05-14 1980-05-14 Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments

Publications (1)

Publication Number Publication Date
IN152828B true IN152828B (en:Method) 1984-04-14

Family

ID=9241965

Family Applications (1)

Application Number Title Priority Date Filing Date
IN513/CAL/81A IN152828B (en:Method) 1980-05-14 1981-05-14

Country Status (23)

Country Link
EP (1) EP0040144B1 (en:Method)
JP (1) JPS6051482B2 (en:Method)
KR (1) KR840001753B1 (en:Method)
AR (1) AR229510A1 (en:Method)
AT (1) AT384428B (en:Method)
AU (1) AU535791B2 (en:Method)
CA (1) CA1181744A (en:Method)
DE (1) DE3165361D1 (en:Method)
DK (1) DK168824B1 (en:Method)
DZ (1) DZ294A1 (en:Method)
ES (1) ES8206555A1 (en:Method)
FI (1) FI67865C (en:Method)
FR (1) FR2482611B1 (en:Method)
GR (1) GR82283B (en:Method)
HU (1) HU188667B (en:Method)
IE (1) IE51283B1 (en:Method)
IL (1) IL62866A (en:Method)
IN (1) IN152828B (en:Method)
MA (1) MA19143A1 (en:Method)
NO (1) NO156129C (en:Method)
NZ (1) NZ197081A (en:Method)
PT (1) PT73024B (en:Method)
ZA (1) ZA813176B (en:Method)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548672A1 (fr) * 1983-07-04 1985-01-11 Pharmuka Lab Oligosaccharides sulfates et leur utilisation comme medicaments
DE3422407A1 (de) * 1984-06-16 1986-03-06 B. Braun Melsungen Ag, 3508 Melsungen Verwendung von heparinderivaten zur selektiven extrakorporalen praezipitation von low-density-lipoproteinen aus vollserum oder plasma
EP0209924A1 (en) * 1985-07-12 1987-01-28 Akzo N.V. New anti-trombosis agent based on glycosaminoglycan, process for its preparation, and pharmaceutical compositions
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
ES2003197A6 (es) * 1987-01-05 1988-10-16 Rovi Lab Farmaceut Sa Procedimiento de despolimerizacion de la heparina para la obtencion de una heparina de bajo peso molecular dotada de actividad antitrombotica
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1230582B (it) 1988-10-21 1991-10-28 Opocrin S P A Lab Farmabiologi Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica
IT1234826B (it) * 1989-01-30 1992-05-29 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
US5340932A (en) * 1989-08-18 1994-08-23 Ajorca S.A. Substances with heparin-like structure and their method of production
DE4121115B9 (de) * 1990-06-26 2005-09-29 Aventis Pharma S.A. Gemische sulfatierter Polysaccharide mit der Grundstruktur der das Heparin bildenden Polysaccharide und mit niedrigem Molekulargewicht, deren Herstellungsverfahren und Verwendung
USRE38743E1 (en) 1990-06-26 2005-06-14 Aventis Pharma S.A. Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events
FR2663639B1 (fr) * 1990-06-26 1994-03-18 Rhone Poulenc Sante Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
US5707973A (en) * 1991-04-23 1998-01-13 Rhone-Poulenc Rorer S.A. Sulfated polysaccharids for treatment or prevention of thromboses
IT1256236B (it) * 1992-12-23 1995-11-29 Mediolanum Farmaceutici Srl Oligosaccaridi aventi attivita' biologica e procedimento per la loro preparazione di glicosaminoglicani
ES2077533B1 (es) * 1994-02-28 1996-07-01 Bioiberica Procedimiento de obtencion de fracciones de oligosacaridos por despolimerizacion quimica de heparina.
JP4498471B2 (ja) * 1996-11-27 2010-07-07 アヴェンティス ファーマシューティカルズ インコーポレイテッド 抗―Ｘａ活性を有する化合物及び血小板凝集拮抗剤化合物を含有する製薬組成物
AUPO556297A0 (en) * 1997-03-11 1997-04-10 Australian National University, The Sulfated oligosaccharides having anticoagulant/ antithrombotic activity
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
FR2811992B1 (fr) * 2000-07-21 2003-07-04 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US6969705B2 (en) * 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
DE60218642T2 (de) * 2002-06-20 2007-11-29 Chemi S.P.A., Cinisello Balsamo Verfahren zur Herstellung von Heparinestern
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
DE10260958A1 (de) * 2002-12-20 2004-07-08 Sustech Gmbh & Co. Kg Kompositmaterialien aus Calciumverbindungen und Glucuronsäure- und/oder Iduronsäurehaltigen Polysacchariden
US7956046B2 (en) 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
ITMI20031679A1 (it) * 2003-08-29 2005-02-28 Opocrin Spa Processo per la produzione di eparine a basso peso
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
US20050261241A1 (en) 2004-05-19 2005-11-24 Celsus Biopharmaceuticals, Inc. Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses
ATE552004T1 (de) 2005-11-30 2012-04-15 Istituto G Ronzoni Oral verabreichbare heparinderivate
ES2340902B1 (es) * 2008-07-01 2011-05-03 Laboratorios Farmaceuticos Rovi, S.A. Composicion farmaceutica con glicosaminoglicanos y su uso en tratamiento de ulceras cronicas.
EP2617737B1 (en) * 2010-09-14 2017-03-01 University Of Miyazaki High purity heparin and production method therefor
FI3724235T3 (fi) 2017-12-11 2024-09-27 Biological E Ltd Menetelmä pienimolekyylipainoisen hepariinin valmistamiseksi
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
AU2020310172A1 (en) 2019-07-09 2022-03-03 Optimvia Llc Methods for synthesizing anticoagulant polysaccharides
ES2792298B2 (es) * 2020-04-27 2022-04-20 Farm Rovi Lab Sa Procedimiento para la obtencion de heparinas de bajo peso molecular y heparinas de bajo peso molecular obtenidas por el mismo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3835112A (en) * 1970-06-08 1974-09-10 Etude Et D Exploit De Marques Heparin esters
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity

Also Published As

Publication number Publication date
MA19143A1 (fr) 1981-12-31
DZ294A1 (fr) 2004-09-13
HU188667B (en) 1986-05-28
HUT34769A (en) 1985-04-28
IL62866A0 (en) 1981-07-31
AR229510A1 (es) 1983-09-15
GR82283B (en:Method) 1984-12-13
AU535791B2 (en) 1984-04-05
FI67865B (fi) 1985-02-28
AT384428B (de) 1987-11-10
AU7051981A (en) 1981-11-19
PT73024B (fr) 1982-07-01
FR2482611A1 (fr) 1981-11-20
EP0040144A1 (fr) 1981-11-18
IL62866A (en) 1984-06-29
FI811469L (fi) 1981-11-15
JPS6051482B2 (ja) 1985-11-14
FI67865C (fi) 1985-06-10
DE3165361D1 (en) 1984-09-13
DK211981A (da) 1981-11-15
ES502199A0 (es) 1982-08-16
JPS5710601A (en) 1982-01-20
EP0040144B1 (fr) 1984-08-08
IE51283B1 (en) 1986-11-26
DK168824B1 (da) 1994-06-20
KR830006333A (ko) 1983-09-24
NO811632L (no) 1981-11-16
ES8206555A1 (es) 1982-08-16
ZA813176B (en) 1982-05-26
FR2482611B1 (fr) 1986-03-07
PT73024A (fr) 1981-06-01
NO156129B (no) 1987-04-21
ATA213681A (de) 1987-04-15
NO156129C (no) 1987-07-29
IE811074L (en) 1981-11-14
CA1181744A (fr) 1985-01-29
NZ197081A (en) 1984-07-31
KR840001753B1 (ko) 1984-10-19

Similar Documents

Publication Publication Date Title
FR2474309B1 (en:Method)
DE3152453A1 (en:Method)
DE3152566T1 (en:Method)
FR2474136B1 (en:Method)
CH655403B (en:Method)
IN152828B (en:Method)
FR2474101B1 (en:Method)
FR2474195B1 (en:Method)
CH660829GA3 (en:Method)
FR2473037B1 (en:Method)
CH655603B (en:Method)
FR2473431B1 (en:Method)
CH657201B (en:Method)
CH655393B (en:Method)
FR2473488B1 (en:Method)
DE3050632A1 (en:Method)
FR2473733B1 (en:Method)
FR2473436B1 (en:Method)
FR2472958B1 (en:Method)
FR2473561B1 (en:Method)
CH655450B (en:Method)
FR2473924B1 (en:Method)
FR2473532B1 (en:Method)
FR2474255B1 (en:Method)
FR2457100B1 (en:Method)